montelukast
Selected indexed studies
- Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. (JAMA Netw Open, 2022) [PMID:35608857]
- Montelukast. (Drugs, 1998) [PMID:9711449]
- Montelukast as a potential treatment for COVID-19. (Expert Opin Pharmacother, 2023) [PMID:36927284]
_Worker-drafted node — pending editorial review._
Connections
montelukast is a side effect of
Sources
- Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. (2022) pubmed
- Montelukast. (1998) pubmed
- Montelukast as a potential treatment for COVID-19. (2023) pubmed
- Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study. (2023) pubmed
- Efficacy of montelukast for adenoid hypertrophy in paediatrics: A systematic review and meta-analysis. (2024) pubmed
- Efficacy and safety of montelukast-levocetirizine combination therapy in combined allergic rhinitis and asthma syndrome: a systematic review and meta-analysis. (2025) pubmed
- Deprescribing montelukast in children with asthma: a systematic review. (2022) pubmed
- Montelukast treatment of urticaria. (2006) pubmed
- The Effect of Oral Montelukast in Controlling Asthma Attacks in Children: A Randomized Double-blind Placebo Control Study. (2023) pubmed
- EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS INDUCED BY MONTELUKAST. (2024) pubmed